Index
By TNW
About Index
Trending news
Lists
Pricing
Sign up or sign in
Syntimmune
3945
Syntimmune
Health Care
Technology
Biotechnology
Medical
Pharmaceuticals
Founded in 2013, Syntimmune is the worlds leader in the biology of the neonatal Fc receptor (FcRn). Syntimmune's lead program targets FcRn.
Suggest edits
Founded
2013
Raised
$84M
Follow us
Contributors
Also headquartered in New York
Verizon
IBM
HBO
Kickstarter
Wired
Goldman Sachs
AOL
Bloomberg
Time Warner
Tumblr
Companies in the same industry
VentiRx Pharmaceuticals
RxAdvance
Rgenix
Euclises Pharmaceuticals
Ironwood Pharma
Neuraltus Pharmaceuticals
Esperion Therapeutics
eXIthera Pharmaceuticals
Viventia Bio Inc.
Athersys Inc
Alexa global traffic share
